Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Lantern Pharma Inc. (LTRN)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/08/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 58.7k | $4.40 | $258.3k | By Bios Fund I QP, LP | 11/08/2022 |
| 11/08/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 100.4k | $4.40 | $441.7k | By Bios Fund I, LP | 11/08/2022 |
| 11/08/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 17.7k | $4.40 | $78.1k | By Bios Fund II NT, LP | 11/08/2022 |
| 11/08/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 132.6k | $4.40 | $583.3k | By Bios Fund II QP, LP | 11/08/2022 |
| 11/08/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 40.6k | $4.40 | $178.6k | By Bios Fund II, LP | 11/08/2022 |
| 11/08/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 58.7k | $4.40 | $258.3k | By Bios Fund I QP, LP | 11/08/2022 |
| 11/08/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 100.4k | $4.40 | $441.7k | By Bios Fund I, LP | 11/08/2022 |
| 11/08/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 17.7k | $4.40 | $78.1k | By Bios Fund II NT, LP | 11/08/2022 |
| 11/08/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 132.6k | $4.40 | $583.3k | By Bios Fund II QP, LP | 11/08/2022 |
| 11/08/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 40.6k | $4.40 | $178.6k | By Bios Fund II, LP | 11/08/2022 |
| 10/20/2022 | Maccecchini Maria-Luisa | Director | Grant | Stock Option (Right to Buy) | 3.2k | $4.79 | $15.3k | | 10/20/2022 |
| 09/02/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 5.2k | $5.20 | $26.9k | By BP Directors, LP | 09/02/2022 |
| 09/02/2022 | Fletcher Aaron G.L. | 10% Owner | Sale | Common Stock | 1.3k | $5.20 | $6.6k | By BP Directors, LP | 09/02/2022 |
| 09/02/2022 | Fletcher Aaron G.L. | 10% Owner | Exercise (in-the-money or at-the-money) | Stock Option | 26.1k | $1.03 | $26.9k | By BP Directors, LP | 09/02/2022 |
| 09/02/2022 | Fletcher Aaron G.L. | 10% Owner | Exercise (in-the-money or at-the-money) | Stock Option | 6.4k | $1.03 | $6.6k | By BP Directors, LP | 09/02/2022 |
| 09/02/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 5.2k | $5.20 | $26.9k | By BP Directors,LP | 09/02/2022 |
| 09/02/2022 | Kreis Leslie W. | 10% Owner | Sale | Common Stock | 1.3k | $5.20 | $6.6k | By BP Directors,LP | 09/02/2022 |
| 09/02/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Stock Option | 26.1k | $1.03 | $26.9k | By BP Directors,LP | 09/02/2022 |
| 09/02/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Stock Option | 6.4k | $1.03 | $6.6k | By BP Directors,LP | 09/02/2022 |
| 08/06/2022 | SHARMA PANNA | President and CEO | Grant | Stock Option (Right to Buy) | 100k | $5.60 | $560k | | 08/06/2022 |
| 03/17/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Common Stock | 60.4k | $189,152.16 | $11430.8M | Bios Fund I, LP | 03/17/2022 |
| 03/17/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Common Stock | 35.3k | $110,636.11 | $3910.7M | Bios Fund I QP, LP | 03/17/2022 |
| 03/17/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Series A Warrants | 60.4k | $0.00 | $0 | Bios Fund I, LP | 03/17/2022 |
| 03/17/2022 | Kreis Leslie W. | 10% Owner | Exercise (in-the-money or at-the-money) | Series A Warrants | 35.3k | $0.00 | $0 | Bios Fund I QP, LP | 03/17/2022 |
| 11/04/2021 | Kreis Leslie W. | 10% Owner | Grant | Stock Option | 3.2k | $10.32 | $33k | By BP Directors, LP | 11/04/2021 |
| 11/04/2021 | KEYSER D JEFFREY | Director | Grant | Stock Option (Right to Buy) | 3.2k | $10.32 | $33k | | 11/04/2021 |
| 11/04/2021 | PRENDERGAST FRANKLYN G | Director | Grant | Stock Option (Right to Buy) | 3.2k | $10.32 | $33k | | 11/04/2021 |
| 11/04/2021 | Silberstein David S. | Director | Grant | Stock Option (Right to Buy) | 3.2k | $10.32 | $33k | | 11/04/2021 |
| 11/04/2021 | Chandru Vijay | Director | Grant | Stock Option (Right to Buy) | 3.2k | $10.32 | $33k | | 11/04/2021 |
| 10/29/2021 | Bhatia Kishor G. | Chief Scientific Officer | Grant | Stock Option (Right to Buy) | 17.4k | $10.21 | $177.7k | | 10/29/2021 |
| 10/29/2021 | Margrave David R. | CFO | Grant | Stock Option (Right to Buy) | 26.1k | $10.21 | $266.5k | | 10/29/2021 |
| 06/16/2020 | Green Park & Golf Ventures II, LLC | | Conversion | Series A Preferred Stock, par value $0.01 | 75.7k | $0.00 | $0 | See footnote | 06/15/2020 |
| 06/15/2020 | Green Park & Golf Ventures II, LLC | | Conversion | Common Stock, par value $0.0001 | 41.5k | $0.00 | $0 | See footnote | 06/15/2020 |
| 06/15/2020 | Green Park & Golf Ventures II, LLC | | Conversion | Common Stock, par value $0.0001 | 292.6k | $0.00 | $0 | See footnote | 06/15/2020 |
| 06/15/2020 | Green Park & Golf Ventures II, LLC | | Conversion | Common Stock, par value $0.0001 | 131.7k | $0.00 | $0 | See footnote | 06/15/2020 |
|
|